Skip to main content
. 2010 Feb 11;5(2):e9166. doi: 10.1371/journal.pone.0009166

Figure 5. Comparing marker contributions to case-control separation for MDD versus schizophrenia.

Figure 5

The Variable Importance of Contribution (VIP) from PLS-DA for each analyte is plotted on X axis for MDD and on the Y axis for schizophrenia. The overlap between the two groups of markers highlights findings that are in common between the two disease groups.